Stay updated on B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.
Latest updates to the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check15 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference2%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has added new features, while several detailed data fields and options for downloading study information have been removed.SummaryDifference3%
- Check36 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference4%
- Check51 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
- Check58 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.1%
Stay in the know with updates to B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.